PharmAsia Market Study July 2000


Regular Price: USD 1,000.00

Special Price USD 700.00

30% OFF

* Required Fields

Regular Price: USD 1,000.00

Special Price USD 700.00


Be the first to review this product

Table of Contents

PharmAsia Market Study July 2000, July 2000 Market Study Cardiovascular Diseases in JapanOverview and ScopeOverview and ScopeMarket Engineering Analysis of the Japanese Hyperlipidemia Market (1996-2006)Market DefinitionsMarket Engineering Research Measurement SystemChallenges Facing the Antihyperlipidemic Market in JapanMarket Engineering Valuation and Revenue Forecasts (1996-2006)Market Engineering Research Analysis of HyperlipidemiaCompetitive StructureProducts in the PipelineMarket Engineering Strategic RecommendationsMarket Engineering Strategic RecommendationsAdd Value to Products by Preventing New Risk Factors for ArterioscelerosisDevelop Combination Drug Therapy forHyperlipidemia; Hypertension and DiabetesFocus on Superiority of New HMG-CoA Reductase Inhibitors in Terms of Its Reduced Side EffectsExplore Other Markets Where Efficacy Is the Primary Criterion for Antihyperlipidemia Product SelectionStrengthen Rapport with Doctors by Providing Value Added InformationDevelop Complementary Antihyperlipidemics for HMG-CoA Reductase Inhibitors

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.